These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25390746)

  • 1. Cholesterol metabolism and immunity.
    Simon A
    N Engl J Med; 2014 Nov; 371(20):1933-5. PubMed ID: 25390746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevalonate kinase deficiency, a metabolic autoinflammatory disease.
    van der Burgh R; Ter Haar NM; Boes ML; Frenkel J
    Clin Immunol; 2013 Jun; 147(3):197-206. PubMed ID: 23110805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon.
    Reboldi A; Dang EV; McDonald JG; Liang G; Russell DW; Cyster JG
    Science; 2014 Aug; 345(6197):679-84. PubMed ID: 25104388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adult hyper-IgD syndrome with canakinumab.
    Curtis CD; Fox CC
    J Allergy Clin Immunol Pract; 2015; 3(5):817-8. PubMed ID: 26116953
    [No Abstract]   [Full Text] [Related]  

  • 5. Mevalonate kinase deficiency presenting as recurrent rectal abscesses and perianal fistulae.
    Dunn K; Pasternak B; Kelsen JR; Sullivan KE; Dawany N; Wright BL
    Ann Allergy Asthma Immunol; 2018 Feb; 120(2):214-215. PubMed ID: 29290516
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses.
    Yi T; Wang X; Kelly LM; An J; Xu Y; Sailer AW; Gustafsson JA; Russell DW; Cyster JG
    Immunity; 2012 Sep; 37(3):535-48. PubMed ID: 22999953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency.
    Marcuzzi A; Decorti G; Pontillo A; Ventura A; Tommasini A
    Inflamm Res; 2010 May; 59(5):335-8. PubMed ID: 20174853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency.
    Munoz MA; Jurczyluk J; Mehr S; Chai RC; Arts RJW; Sheu A; McMahon C; Center JR; Singh-Grewal D; Chaitow J; Campbell DE; Quinn JMW; Alexandrov K; Tnimov Z; Tangye SG; Simon A; Phan TG; Rogers MJ
    J Allergy Clin Immunol; 2017 Sep; 140(3):873-875.e6. PubMed ID: 28501347
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
    Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
    Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for geranylgeranylation in interleukin-1beta secretion.
    Mandey SH; Kuijk LM; Frenkel J; Waterham HR
    Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary hypothesis of the Mevalonate Kinase Deficiency.
    Vuch J; Marcuzzi A; Bianco AM; Tommasini A; Zanin V; Crovella S
    Med Hypotheses; 2013 Jan; 80(1):67-9. PubMed ID: 23168296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous manifestations in mevalonate kinase deficient patients treated with canakinumab.
    Conte M; Pastore S; Berti I; Taddio A; Tommasini A
    Clin Exp Rheumatol; 2020; 38(4):760-762. PubMed ID: 32324125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mevalonate kinase deficiency and autoinflammation.
    Hager EJ; Gibson KM
    N Engl J Med; 2007 Nov; 357(18):1871-2. PubMed ID: 17978300
    [No Abstract]   [Full Text] [Related]  

  • 14. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice.
    Michaud J; Kohno M; Proia RL; Hla T
    FEBS Lett; 2006 Aug; 580(19):4607-12. PubMed ID: 16876794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe early-onset colitis revealing mevalonate kinase deficiency.
    Levy M; Arion A; Berrebi D; Cuisset L; Jeanne-Pasquier C; Bader-Meunier B; Jung C
    Pediatrics; 2013 Sep; 132(3):e779-83. PubMed ID: 23979089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperimmunoglobulin D syndrome in an Indian family undiagnosed for 11 years.
    Abdulla MC; Hawkins PN; Alungal J; Rowczenio D
    Int J Rheum Dis; 2017 Dec; 20(12):2236-2237. PubMed ID: 26620804
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of interleukin-1 inhibiton for mevalonate kinase deficiency].
    Horneff G
    Z Rheumatol; 2014 Jun; 73(5):398. PubMed ID: 25057522
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: 25-Hydroxycholesterol: a new life in immunology.
    McDonald JG; Russell DW
    J Leukoc Biol; 2010 Dec; 88(6):1071-2. PubMed ID: 21123296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.
    Musumeci G; Grasselli G; Rossi S; De Chiara V; Musella A; Motta C; Studer V; Bernardi G; Haji N; Sepman H; Fresegna D; Maccarrone M; Mandolesi G; Centonze D
    Neurobiol Dis; 2011 Sep; 43(3):669-77. PubMed ID: 21672630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferons have opposing effects during the emergence and recovery phases of colitis.
    Rauch I; Hainzl E; Rosebrock F; Heider S; Schwab C; Berry D; Stoiber D; Wagner M; Schleper C; Loy A; Urich T; Müller M; Strobl B; Kenner L; Decker T
    Eur J Immunol; 2014 Sep; 44(9):2749-60. PubMed ID: 24975266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.